HSPG2 and cancer: Moreover, our studies have a potential translational impact in the field of cancer: we envision prevention of premature senescence of fibroblasts within the TME, using either P2Y11R or PLC inhibitors, as possible alternative therapeutic options aimed at blocking or limiting the growth of TNBC cells at metastatic sites.